PuSH - Publication Server of Helmholtz Zentrum München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Merle, M.* ; Fischbacher, D.* ; Liepert, A.* ; Grabrucker, C.* ; Kroell, T.* ; Kremser, A.* ; Dreyssig, J.* ; Freudenreich, M.* ; Schuster, F.* ; Borkhardt, A.* ; Kraemer, D.* ; Koehne, C.H.* ; Kolb, H.J. ; Schmid, C.* ; Schmetzer, H.

Conversion of AML-blasts to leukemia-derived dendritic cells (DCleu) in 'DC-culture-media' shifts correlations of released chemokines with antileukemic T-cell reactions.

Immunobiology 226:152088 (2021)
DOI PMC
Dendritic cells (DC) and T-cells are mediators of CTL-responses. Autologous (from patients with acute myeloid leukaemia (AML) or myelodysplasia (MDS)) or allogeneic (donor)-T-cells stimulated by DCleu, gain an efficient lysis of naive blasts, although not in every case. CXCL8, -9, -10, CCL2, -5 and Interleukin (IL-12) were quantified by Cytometric Bead Array (CBA) in supernatants from 5 DC-generating methods and correlated with AML-/MDS-patients' serum-values, DC-/T-cell-interactions/antileukemic T-cell-reactions after mixed lymphocyte culture (MLC) and patients' clinical course. The blast-lytic activity of T-cells stimulated with DC or mononuclear cells (MNC) was quantified in a cytotoxicity assay. Despite great variations of chemokine-levels, correlations with post-stimulation (after stimulating T-cells with DC in MLC) improved antileukemic T-cell activity were seen: higher released chemokine-values correlated with improved T-cells' antileukemic activity (compared to stimulation with blast-containing MNC) - whereas with respect to the corresponding serum values higher CXCL8-, -9-, and -10- but lower CCL5- and -2-release correlated with improved antileukemic activity of DC-stimulated (vs. blast-stimulated) T-cells. In DC-culture supernatants higher chemokine-values correlated with post-stimulation improved antileukemic T-cell reactivity, whereas higher serum-values of CXCL8, -9, and -10 but lower serum-values of CCL5 and -2 correlated with post-stimulation improved antileukemic T-cell-reactivity. In a context of 'DC'-stimulation (vs serum) this might point to a change of (CCL5 and -2-associated) functionality from a more 'inflammatory' or 'tumor-promoting' to a more 'antitumor'-reactive functionality. This knowledge could contribute to develop immune-modifying strategies that promote antileukemic (adaptive) immune-responses.
Impact Factor
Scopus SNIP
Scopus
Cited By
Altmetric
3.144
0.000
1
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Scientific Article
Keywords Acute Myeloid Leukemia ; Chemokines ; Dendritic Cells ; Immunotherapy ; T-cells; Acute Myeloid-leukemia; Antigen-presenting Cells; Serum-free Generation; Ex-vivo; Myelodysplastic Syndrome; Protective Immunity; Tumor-cells; Transplantation; Polarization; Maturation
Language english
Publication Year 2021
HGF-reported in Year 2021
ISSN (print) / ISBN 0171-2985
e-ISSN 1878-3279
Journal Immunobiology : Experimental and Clinical
Quellenangaben Volume: 226, Issue: 3, Pages: , Article Number: 152088 Supplement: ,
Publisher Urban & Fischer
Publishing Place Hackerbrucke 6, 80335 Munich, Germany
Reviewing status Peer reviewed
Institute(s) CCG Immunotherapy (KKG-KIT)
POF-Topic(s) 30504 - Mechanisms of Genetic and Environmental Influences on Health and Disease
Research field(s) Immune Response and Infection
PSP Element(s) G-520360-001
DOI 10.1016/j.imbio.2021.152088
WOS ID WOS:000656106100010
Scopus ID 85103992054
PubMed ID 33838552
Erfassungsdatum 2021-05-28
[➜Report correction]